Monday, November 25, 2024
HomeTagsMolecule cMET inhibitor

molecule cMET inhibitor

IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib Combination and Successful FDA Type C Meeting on Registrational Trial Design for Accelerated...

IDEAYA Biosciences, Inc, a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced further interim results from its Phase...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics